Sep 05, 2019

Huntsman Cancer Institute Breaks Ground on 205,000-Square-Foot Expansion of Cancer Hospital

Today patients, donors, dignitaries, and staff of Huntsman Cancer Institute celebrated the groundbreaking of the next major expansion on the cancer campus. The Kathryn F. Kirk Center for Comprehensive Cancer Care and Women’s Cancers at HCI will contain eight stories, with a floor dedicated to women’s cancers; a new endoscopy center; increased services for blood and marrow transplant patients; an expansion of the HCI Wellness and Integrative Health Center; and 48 new inpatient hospital rooms

Aug 19, 2019

Huntsman Cancer Institute Introduces Cancer Screening and Education Bus to the Community

Huntsman Cancer Institute (HCI) at the University of Utah unveiled the Cancer Screening and Education bus. This new, state-of-the-art mobile outreach clinic brings HCI’s clinical and educational expertise and the latest screening technology to residents across Utah, including those who live in distant geographic areas and rural communities. The mobile outreach vehicle is a collaboration between HCI and University of Utah Health (U of U Health) and will offer health education and screening services for breast cancer and skin cancer.

Aug 15, 2019

Discovery of How Cells Override Genetic Changes Could Lead to New Approaches in Pancreatic Cancer Treatment

Pancreatic cancer is one of the deadliest cancers. It is difficult to diagnose, is often not found until it has spread to other parts of the body, and is mostly untreatable. A discovery by scientists at Huntsman Cancer Institute at the University of Utah could lead researchers to a more effective way to treat pancreatic cancer.

Aug 01, 2019

BRIGHT Study Finds Genetic Testing Motivates Behavior Changes in Families at Risk for Melanoma

Skin cancer is the most commonly diagnosed cancer in the United States, and melanoma is the most severe type of skin cancer. Utah has a particularly high melanoma rate. A new study led by researchers at Huntsman Cancer Institute collaborators at Northwestern University and Oregon Health and Science University investigated whether genetic testing would motivate people at risk of developing melanoma to alter their behavior in order to reduce their risk.

Jul 18, 2019

Huntsman Cancer Institute Researchers Develop Potential New Treatment for MYC-driven Small Cell Lung Cancer

Lung cancer is the leading cause of cancer death among men and women in Utah and the United States. Often, symptoms do not appear until the disease is advanced. Therefore, research studies toward better practices to prevent, find, and treat lung cancer are paramount. Research from scientists at Huntsman Cancer Institute yielded new insights into understanding potential new treatment options for MYC-driven tumors, a distinct subtype of small cell lung cancer.

Jul 09, 2019

Possible ‘Achilles Heel’ Discovered in Developing Better Drug Treatment in Cancers with Overactive Smoothened Protein

One of the most significant obstacles cancer patients face is resistance to drug treatment. Aggressive tumors often become adept at resisting the powerful drugs used to combat them. Therapeutic agents that were effective at one point may become ineffective as a patient’s tumor evolves and learns to fight the drug. A recent discovery could lead to a better understanding of how cancer patients develop drug resistance.

Jul 03, 2019

Huntsman Cancer Institute Researchers Discover Melanoma Can Spread without Tumor Growth

Utah has the highest rate of melanoma in the United States. Melanoma is an aggressive skin cancer that spreads quickly. Allie Grossmann, MD, PhD, focuses on identifying better ways to treat this lethal cancer. In a study recently published by the journal Cancer Research, Grossmann details one of the factors behind how and why melanoma metastasizes so quickly.

Jul 01, 2019

Sigma Chi Fraternity Pledges $20 Million Dedicated to Women's Cancer Research

Last week, Sigma Chi International Fraternity announced a new $20-million pledge to Huntsman Cancer Foundation, dedicated to and used for women’s cancer research, treatment and wellness at Huntsman Cancer Institute.

Jun 19, 2019

Huntsman Cancer Institute Research Discovery Leads to New Clinical Trial for Myelofibrosis Patients

Researchers at Huntsman Cancer Institute at the University of Utah discovered in laboratory studies that an experimental drug called selinexor may block a crucial survival pathway exploited by myelofibrosis cells.

Jun 12, 2019

Determining Risk of Recurrence in Triple-Negative Breast Cancer

A personalized prognosis for patients diagnosed with triple-negative breast cancer was the goal of a new study by Katherine Varley, PhD, researcher at Huntsman Cancer Institute (HCI) and assistant professor of oncological sciences at the University of Utah.

May 31, 2019

International Clinical Trial of New Drug for Men with Advanced Prostate Cancer Yields Strong Results

Today the New England Journal of Medicine published the first results of a phase III international clinical study called TITAN, which evaluated the effectiveness and safety of a new drug, apalutamide, to treat advanced prostate cancers.

May 13, 2019

New Insights into Treatment Targets for Men with Advanced Prostate Cancers

In the largest study of its kind, more than half of patients with advanced prostate cancers appear to be strong candidates for targeted cancer therapies

Apr 23, 2019

Air Pollution Poses Risks for Childhood Cancer Survivors

Poor air quality days significantly increase the risk of hospitalizations for respiratory issues in young survivors of cancer, according to a study conducted by researchers at Huntsman Cancer Institute (HCI) at the University of Utah (U of U) and published in the International Journal of Environmental Research and Public Health.

Mar 14, 2019

Huntsman Cancer Institute applauds the Utah State Legislature for raising the age of sale for tobacco products to 21

Huntsman Cancer Institute (HCI) at the University of Utah applauds the bold actions taken by the Utah State Legislature this week in addressing tobacco-related health issues. The state’s approval of a policy that incrementally increases the age from 19 to 21 for the sale and use of tobacco products, e-cigarettes, and vaping devices—a policy called Tobacco 21—is a step that will ensure Utah remains a national leader in health by reducing tobacco-related illnesses and protecting youth from nicotine addiction.

Mar 13, 2019

How Barbershops Will Play a Role in Reducing Colorectal Cancer Disparities among African-American Men

African-American men are more likely to die from colon cancer than any other racial group. That fact led a researcher at Huntsman Cancer Institute (HCI) at the University of Utah (U of U) to begin a long-term project to understand why.

Mar 04, 2019

Promising New Pancreatic Cancer Treatment Moves Forward

A study published today in the journal Nature Medicine led by researchers at Huntsman Cancer Institute (HCI) at the University of Utah (U of U) describes a new therapeutic approach with potential for patients with pancreatic cancer. These researchers discovered a combination drug therapy that may effectively combat the disease. HCI researchers first observed anti-cancer impacts in a laboratory setting and, subsequently, in its first use in a human patient.

Feb 04, 2019

New Study Shows Cost Effectiveness of Early Cancer Surveillance for Patients Who Have a High Risk of Developing Cancer

New research published today in the journal Pediatric Blood and Cancer shows how early cancer screening and surveillance in patients with Li-Fraumeni Syndrome (LFS) results in additional years of life, and is cost effective for third-party payers.

Feb 01, 2019

Huntsman Cancer Institute’s Renovated ‘Beacon of Hope’ Will Light in Remembrance of Founder, Jon M. Huntsman

Jon M. Huntsman, Sr. was a visionary philanthropist who made it his personal mission to eradicate cancer from the face of the Earth. He often described his devastation after the loss of several family members and close friends to the disease. In the 1990s, he received his first of four cancer diagnoses. His personal experiences with cancer ignited a determination to make a difference. After he completed treatments, Huntsman and his family vowed to use their considerable means to transform the experience for cancer patients and to advance research. Vision began its course to reality with the founding a cancer center that would bear the Huntsman family name.

Jan 11, 2019

Huntsman Cancer Institute’s Next Expansion for Cancer Patients Nearly Doubles in Size Thanks to a $30 Million Gift from the Huntsman Foundation

Peter Huntsman, CEO of the Huntsman Foundation and chairman and CEO of the Huntsman Cancer Foundation (HCF), announced today a transformational $30 million gift from the family’s foundation. This donation allows Huntsman Cancer Institute (HCI) at the University of Utah (U of U) to better plan for and address the future needs of cancer patients in the Mountain West. The gift is in addition to the $40 million already raised by HCF to support the construction of the Kathryn F. Kirk Center for Comprehensive Cancer Care and Women’s Cancers at Huntsman Cancer Institute.

Jan 09, 2019

Huntsman Cancer Institute Helps Develop BRCA Exchange to Inform Understanding of Cancer Risk by Aggregating Data on Thousands of BRCA1 and BRCA2 Mutations

Researchers at Huntsman Cancer Institute (HCI) at the University of Utah (U of U) contributed to the development of a global resource that includes data on thousands of inherited variants in the BRCA1 and BRCA2 genes. This resource, called the BRCA Exchange, is now available to the public. The BRCA Exchange was created through the BRCA Challenge, a long-term demonstration project initiated by the Global Alliance for Genomics and Health (GA4GH) to enhance sharing of BRCA1/BRCA2 data. The new resource will allow clinicians to review expert classifications of variants in these major cancer predisposition genes as part of their individual assessment of cancer prevention, screenings, and interventions for patients at higher risk for breast, ovarian, and certain other cancers.

Dec 13, 2018

Huntsman Cancer Institute Launches Innovative Service Providing Cancer Care at Home

Huntsman Cancer Institute at the University of Utah has launched a unique new service called Huntsman at Home. This service brings HCI-quality care into the homes of HCI patients, whose medical needs range from symptom management to physical therapy after cancer surgery to end-of-life care. Huntsman at Home may also allow patients to be discharged from the HCI cancer hospital sooner by enabling them to receive follow-up care in their own home.

Dec 10, 2018

Researchers Develop Personalized Medicine Tool for Inherited Colorectal Cancer Syndrome Risk

An international team of researchers led by Huntsman Cancer Institute at the University of Utah has developed, calibrated, and validated a novel tool for identifying the genetic changes in Lynch syndrome genes that are likely to be responsible for causing symptoms of the disease. The results were published in the journal Genetics in Medicine.

Nov 20, 2018

The Pancreatic Cancer Collective awards $7 million in first-round “New Therapies Challenge” Grants

The Pancreatic Cancer Collective, the strategic partnership of the Lustgarten Foundation and Stand Up To Cancer (SU2C), has awarded a total of $7 million in first-round “New Therapies Challenge” grants to seven teams of top cancer researchers to explore new pancreatic cancer treatments, the American Association for Cancer Research, the Scientific Partner of SU2C, announced today. Each team will receive up to $1 million in initial funding, with $4 million per team for clinical studies awaiting the most successful projects in the second round.

Nov 20, 2018

Huntsman Cancer Institute Breaks Ground for Utah’s First Proton Therapy Center

Officials at Huntsman Cancer Institute at the University of Utah began construction on a project that will house the region’s first proton therapy center and announced the new center will be named in honor of United States Senator Orrin G. Hatch. Cancer patients and loved ones joined leaders from HCI, Huntsman Cancer Foundation, and the university to mark the occasion.

Nov 07, 2018

Let’s Talk About Your DNA

An interdisciplinary team of researchers at Huntsman Cancer Institute at the University of Utah was recently awarded a prestigious team science grant through the National Cancer Institute’s Cancer Moonshot initiative to study genetic counseling, genetic communication and genetic services to patients. The grant is expected to provide more than $5 million in research project support over the next five years.

Oct 24, 2018

Utah Cancer Registry Receives Renewal from National Cancer Institute

Huntsman Cancer Institute and the University of Utah will receive up to $28 million over the next 10 years from the National Cancer Institute (NCI) to continue its participation in the NCI’s Surveillance Epidemiology and End Results program.

Oct 16, 2018

A Bad Influence: The Interplay between Tumor Cells and Immune Cells

Research at Huntsman Cancer Institute at the University of Utah yielded new insights into the environment surrounding different types of lung tumors, and described how these complex cell ecosystems may in turn ultimately affect response to treatment. The results were published today in Immunity and featured on the print cover of the journal.

Oct 11, 2018

Study Holds Promise for New Pediatric Brain Tumor Treatment

New research published in Nature Communications from scientists at Huntsman Cancer Institute at the University of Utah, in collaboration with the Stanford University School of Medicine, shows a specific protein regulates both the initiation of cancer spreading and the self-renewal of cancer cells in medulloblastoma, a type of pediatric brain cancer.

Oct 02, 2018

Huntsman Cancer Institute and Grand Valley Oncology Begin Telemedicine Clinic for Blood and Bone Marrow Transplant Patients

Huntsman Cancer Institute at the University of Utah, in partnership with Grand Valley Oncology, recently opened a telemedicine clinic to serve blood and marrow transplant patients in Mesa County, Colorado and the surrounding areas. This service will bring cutting-edge care to remote communities without requiring the patient to travel long distances to Salt Lake City for follow-up appointments.

Sep 20, 2018

Huntsman Cancer Foundation Announces Major Gifts to Support Hospital Expansion Plans

Huntsman Cancer Foundation announces that several individuals and business organizations have committed a total of $40 million to support a proposed major building expansion of Huntsman Cancer Institute at the University of Utah.

Sep 07, 2018

Huntsman Cancer Institute CEO Mary Beckerle, PhD, Honored by YWCA Utah

YWCA Utah has selected Mary Beckerle, PhD, CEO of Huntsman Cancer Institute, to receive the Outstanding Achievement Award in Medicine and Health. Beckerle will be honored today at the 30th annual YWCA Utah LeaderLuncheon.

Aug 07, 2018

Research Identifies New Treatment Targets in Breast Cancer

Scientists at Huntsman Cancer Institute at the University of Utah, in collaboration with the Salk Institute for Biological Studies, have generated the first single cell resolution atlas of genes that control the formation of breast tissue. The atlas provides a comprehensive molecular map that will be used to help researchers understand how breast cancers form and to pinpoint new ways to prevent, diagnose, and treat the disease.

Jul 20, 2018

Huntsman Cancer Institute Named Among Most Beautiful Hospitals in the US

Huntsman Cancer Institute at the University of Utah has been named among a list of the Top 20 Most Beautiful Hospitals in the US.

Jul 13, 2018

Huntsman Cancer Institute Names Cornelia Ulrich as Director of its Cancer Research Center

Huntsman Cancer Institute at the University of Utah today announced the appointment of Cornelia Ulrich, PhD, MS, as director of its National Cancer Institute-Designated Comprehensive Cancer Center. She will oversee HCI’s academic consortium of nearly 200 cancer research teams. Ulrich will lead efforts to advance HCI’s research in laboratory, clinical and population science, with the goal of improving cancer prevention and treatment.

Jul 11, 2018

Huntsman Cancer Institute Researcher Receives Leadership Award from the National Cancer Institute

Huntsman Cancer Institute physician-scientist Ahmad Halwani, MD, has been selected by the National Cancer Institute to receive a Cancer Clinical Investigator Team Leadership Award. This award recognizes physician-scientists for their contributions to clinical cancer research. It also provides financial support for ongoing research and leadership development to enable recipients to further advance their clinical research careers.

Jun 07, 2018

Huntsman Cancer Institute Partners with Nation’s Top Cancer Centers to Endorse Goal of Eliminating HPV Related Cancers in the United States

Nearly 80 million Americans—one out of every four people—are infected with human papillomavirus (HPV). And of those millions, more than 31,000 will be diagnosed with an HPV-related cancer this year. Despite those staggering figures and the availability of a vaccine to prevent the infections that cause these cancers, HPV vaccination remains low in the United States.

May 30, 2018

Huntsman Cancer Institute and TGen receive $6.7 million grant to battle a hidden enemy

Often what kills cancer patients is not the cancer at its original or primary site, but its spread to secondary sites within the body, through a process called metastasis. In the case of breast cancer, the tumor often spreads to the bone, and it is this bone metastasis that results in intense pain and precedes spread to other organs.

May 10, 2018

Huntsman Cancer Institute First Adult Cancer Hospital in Mountain West to Offer CAR T Cell Therapy to Patients

Huntsman Cancer Institute announced today that it has been certified to offer both chimeric antigen receptor (CAR) T cell therapies recently approved by the U.S. Food and Drug Administration. The therapies are approved for types of aggressive blood cancers, including B-cell acute lymphoblastic leukemia and non-Hodgkin lymphoma. HCI is one of a few locations nationwide, and the only in the Mountain West, approved to offer these new therapies to adult cancer patients.

May 08, 2018

Huntsman Cancer Institute Opens Center for HOPE and is Awarded $9.7 Million to Improve Health Among Underserved Populations

Huntsman Cancer Institute at the University of Utah today announced the opening of the Cancer Population Sciences and Huntsman Center for Health Outcomes and Population Equity (HOPE), a new research and clinical space dedicated to preventing cancer and improving health among underserved populations and improving outcomes in cancer patients. The center recently received $9.7 million from the Patient-Centered Outcomes Research Institute to fund a clinical trial researching new and effective approaches to reduce tobacco use.

May 01, 2018

Persistence Pays Off in Discovery That Could Lead to Improved Treatment and Survivability of Patients with Brain Tumors

Gliomas are the most common type of central nervous system cancer but how these tumors develop is not fully understood. Sheri Holmen, PhD a researcher at Huntsman Cancer Institute and professor of surgery at the University of Utah just published the results of her research on gliomas in Cell Reports. The work is focused on a mutated gene that is a critical piece of the puzzle for glioma development, according to Holmen’s work.

Mar 15, 2018

Huntsman Cancer Institute Joins National Clinical Trial Targeting AML

Huntsman Cancer Institute at the University of Utah has been selected to participate in the Beat AML Master Trial, an innovative clinical trial sponsored by The Leukemia & Lymphoma Society. The clinical trial is testing several new targeted therapies for the treatment of patients with acute myeloid leukemia (AML). HCI is the only facility in the Mountain West offering this trial to AML patients.

Mar 13, 2018

Surprising Discovery Provides Insights into Aggressive Endometrial Cancers

New research from Huntsman Cancer Institute at the University of Utah indicates steroid and hormone receptors are simultaneously active in many endometrial cancer tissues. The findings, published today in the journal Cell Reports, yield insights about factors that contribute to more aggressive endometrial tumors.

Feb 20, 2018

Peter R. Huntsman Named Chairman of the Board, Huntsman Cancer Foundation

The Board of Directors of Huntsman Cancer Foundation has elected Peter R. Huntsman as Chairman of the Board effective immediately. He replaces his father, Jon M. Huntsman, Sr., who founded Huntsman Cancer Institute (HCI) and was its principal benefactor. Jon M. Huntsman passed away earlier this month.

Feb 15, 2018

Working in Harmony: New Insights into How Packages of DNA Orchestrate Development

New research from Huntsman Cancer Institute at the University of Utah illuminates aspects of how an early embryo, the product of fertilization of a female egg cell by a male sperm cell, can give rise to all the many cell types of the adult animal. The findings, published in the journal Cell, have significant implications for understanding how early development is orchestrated, and provides a mechanism for how parental environment might impact the expression of these genes in the offspring.

Feb 08, 2018

Huntsman Cancer Institute Lights ‘Beacon of Hope’ in Honor of Jon M. Huntsman

A new lighting installation at Huntsman Cancer Institute (HCI) at the University of Utah honors Jon M. Huntsman’s enduring impact on cancer research and care. The installation, called ‘The Beacon of Hope’ is located within an architectural feature on the west facade of the original HCI research building, and is viewable from the exterior of the building. The newly-designed installation will be lit for the first time at sunset on Friday, February 9, to commemorate weekend memorial services for Huntsman.

Feb 08, 2018

Funeral Services for Jon M. Huntsman

Funeral services for Jon M. Huntsman, will be held on Saturday, February 10, at 11:00 a.m. in the Jon M. Huntsman Center on the campus of the University of Utah, 1825 E. South Campus Drive, Salt Lake City.

Feb 02, 2018

Statement on the Passing of Jon M. Huntsman, HCI Founder

We are truly saddened at the passing of our remarkable founder and benefactor, Jon M. Huntsman, this afternoon. He passed away peacefully at home, surrounded by his loving family. Other than his family, his greatest passion was to eradicate cancer. We will honor his legacy by continuing to provide hope and healing to all impacted by this disease.

Feb 01, 2018

Changes in genes involved in DNA repair and packaging linked to risk of multiple myeloma

Researchers have identified two gene regions that contribute to multiple myeloma, an inherited cancer that occurs in bone marrow, through a new method that makes use of human disease pedigrees. Nicola Camp and Rosalie Waller of Huntsman Cancer Institute at the University of Utah and colleagues report their findings February 1st in PLOS Genetics.

Jan 29, 2018

Huntsman Cancer Institute Selected as a National Cancer Institute Center for Patient-Derived Model Development

Huntsman Cancer Institute has been awarded a $2.4 million, two-year grant from the National Cancer Institute to help continue its research in breast cancer. Alana Welm, PhD and Bryan Welm, PhD, investigators at HCI, along with Michael Lewis, PhD, a colleague at Baylor College of Medicine, will use this new funding to serve as a Breast Cancer Patient-derived xenograft Development and Trials Center to research and test new drugs for breast cancer. This new Center is only one of four such Centers in the nation.

Jan 17, 2018

A Centuries-Old Math Equation Used to Solve a Modern-Day Genetics Challenge

Researchers developed a new mathematical tool to validate and improve methods used by medical professionals to interpret results from clinical genetic tests. The work was published this month in Genetics in Medicine.

Jan 09, 2018

Huntsman Cancer Institute CEO and Director Honored by National Cancer Institute

Mary Beckerle, PhD, CEO and Director of Huntsman Cancer Institute at the University of Utah, is this year’s recipient of the Alfred G. Knudson Award in Cancer Genetics from the National Cancer Institute.

Dec 21, 2017

New Cancer Treatment Technology Coming to Utah

A new cancer treatment technology is one step closer to Salt Lake City. Today Huntsman Cancer Institute (HCI) at the University of Utah (U of U) announced a plan to add a proton therapy center to its Cancer Hospital. The center will be the only one of its kind in the region. The plan will now move forward to the next steps of approval, design and vendor selection.

Nov 27, 2017

Huntsman Cancer Institute Researchers Trace Timeline of Tumor Evolution in Metastatic Breast Cancer Patients

A new study by researchers at Huntsman Cancer Institute (HCI) at the University of Utah observed how breast cancer tumors evolve over time and demonstrated how changes within tumors may contribute to the process by which cancers no longer respond to treatment. Further, the research identifies that some of these changes may be shared across certain treatment-resistant breast cancers. The study was published this month in Nature Communications.

Nov 22, 2017

Risk for Aging-related Diseases Elevated Among Thyroid Cancer Survivors

Risk for aging-related diseases such as heart disease and diabetes was significantly higher among thyroid cancer survivors in Utah than it was among age-matched, cancer-free individuals, with those diagnosed before age 40 having the highest risk for some of the diseases, according to results published in Cancer Epidemiology, Biomarkers & Prevention, a journal of the American Association for Cancer Research

Nov 06, 2017

Huntsman Cancer Institute Study Identifies Enhanced Impact of Treatment for Hereditary Cancer Patients

People with an inherited syndrome called familial adenomatous polyposis (FAP) have a 100% lifetime risk of developing colorectal cancer if they do not seek appropriate medical care. Recent findings published by researchers at Huntsman Cancer Institute at the University of Utah identified a promising prevention treatment for patients with FAP.

Oct 19, 2017

New Study Finds Childhood Cancer Survivors Commonly Stay at Jobs to Keep Health Insurance

The results of a national cancer survey find a significant number of childhood cancer survivors are worried about keeping their health insurance, to the point of letting it affect their career decisions. The findings were published today in JAMA Oncology. Anne Kirchhoff, PhD, investigator at Huntsman Cancer Institute (HCI) at the University of Utah and assistant professor of pediatrics, led the study. Her goal was to examine the prevalence of job lock in full-time, employed childhood cancer survivors. Job lock is when an employee stays at a job in order to keep work-related health insurance.

Oct 05, 2017

New Research on Sperm Stem Cells has Implications for Male Infertility and Cancer

New research from scientists at Huntsman Cancer Institute (HCI) at the University of Utah and collaborators at University of Utah Health (U of U Health) sheds light on the complex process that occurs in the development of human sperm stem cells. This is the first study to characterize the changes human sperm stem cells undergo as they mature. The results have implications for understanding male infertility as well as cancer development and were published today in the journal Cell Stem Cell.

Sep 22, 2017

Huntsman Cancer Institute Announces New Clinical Research Director

Huntsman Cancer Institute (HCI) at the University of Utah has announced David Gaffney, MD, PhD, as Senior Director for Clinical Research. In this position, Gaffney oversees HCI’s clinical research efforts which include more than 200 active clinical cancer trials at any given time.

Sep 01, 2017

Adipose Tissue May Affect Cancer Development in Multiple Ways

Review indicates need to further explore relationship between fat and cancer. Adipose tissue, or fat, may influence the development of cancer in diverse ways, depending on the type of fat and the location in the body, according to results of a systematic review published in Cancer Prevention Research, a journal of the American Association for Cancer Research

Aug 11, 2017

First Lady of the Dominican Republic Visits Huntsman Cancer Institute

Mrs. Cándida Montilla de Medina, First Lady of the Dominican Republic, and her delegation visited Huntsman Cancer Institute (HCI) at the University of Utah yesterday, Thursday, August 10. During her visit, Mrs. Montilla de Medina toured HCI and met with physicians, researchers, Elder Ronald A. Rasband of The Church of Jesus Christ of Latter-day Saints, and members of the Huntsman family, including Jon M. Huntsman, Sr., to learn about HCI’s mission: to research cancer from its beginnings, develop new cancer treatments, and relieve the suffering of cancer patients.

Jul 18, 2017

Study Shows Shorter Course of Radiation May Be a Safe and Convenient Option for Breast Cancer Patients after Mastectomy

Research published in the Journal of Clinical Oncology demonstrates that a shorter course of radiation may be a good option for breast cancer patients who need radiation following mastectomy. The Phase II clinical trial examined the safety of treating women with a three-week course of radiation instead of the traditional six weeks.

Jun 21, 2017

Huntsman Cancer Institute Unveils New Primary Children’s and Families’ Cancer Research Center

State-of-the-Art Facility Opens to Expand Research in Cancers that Affect Children and Families and Accelerate the Development of New Treatments and Cancer Prevention Strategies

Jun 20, 2017

Grand Valley Oncology Announces Clinical Trials Open to Patients

Mesa County, Colo.--- Grand Valley Oncology with the support of Huntsman Cancer Institute (HCI) at the University of Utah will offer a range of clinical trials for their patients. Physicians at Grand Junction Oncology will work closely with their counterparts at HCI to identify opportunities for patients in western Colorado to participate in clinical trials.

Jun 09, 2017

New Cancer Drug Tested In Mice May Benefit Certain Leukemia Patients

SALT LAKE CITY –Almost 6,000 new cases of acute lymphoblastic leukemia, or ALL, are expected to be diagnosed this year in the United States. The blood cancer can affect both children and adults. Scientists have found up to 30 percent of adult ALL patients have what’s called a Philadelphia chromosome, where two segments of chromosomes have aberrantly fused together. (The fusion chromosome is much less common in children.) Adult ALL patients exposed to standard treatments often see high relapse rates, and treatment-related deaths remain high. But researchers at Huntsman Cancer Institute (HCI) at the University of Utah have discovered new science, published this week in the journal Leukemia, that could provide better therapeutic options for patients.

May 30, 2017

Huntsman Cancer Institute at the University of Utah Selected to Join National Cancer Institute’s Systems Biology Consortium

SALT LAKE CITY – Huntsman Cancer Institute (HCI) and the College of Pharmacy at the University of Utah (U of U) have been awarded a $9.1 million, five-year grant from the National Cancer Institute (NCI) to serve as a Research Center in NCI’s Cancer Systems Biology Consortium (CSBC). HCI is one of nine research institutions nationwide to be selected as a Research Center in the CSBC.

May 22, 2017

CEO of Huntsman Cancer Institute Inducted Alongside President Obama to American Philosophical Society

SALT LAKE CITY – Mary Beckerle, PhD, CEO and Director of Huntsman Cancer Institute (HCI) at the University of Utah, has been elected to highly distinguished membership in the American Philosophical Society (APS), joining a group of 32 inductees that includes former United States president Barack Obama.

May 15, 2017

Carson Tahoe Health Opens New Blood and Bone Marrow Transplant Care Clinic

Carson City, Nev. – Today, May 15, Carson Tahoe Cancer Center opened a new blood and bone marrow transplant care clinic with support from the Huntsman Cancer Institute (HCI) at the University of Utah. Under the collaboration, a Bone Marrow Transplant (BMT) physician and nurse from HCI will travel to Carson City once a month to treat patients both before and after they receive a transplant.

May 01, 2017

Huntsman Cancer Institute and Intermountain Healthcare Launch Joint Cancer Care Program for Adolescents and Young Adults

Huntsman Cancer Institute (HCI) at the University of Utah and Intermountain Cancer Centers announce a new collaboration today designed to meet the needs of adolescents and young adults (AYAs) between the ages of 15 and 39 who have been diagnosed with cancer. Each year over 1,000 adolescents and young adults in Utah are diagnosed with cancer, yet research has shown a number of gaps in their care.

Apr 25, 2017

Cognitive Stimulation, Social Interactions & Physical Activity Increase Lifespan in Mice with Colon Cancer

Living in a stimulating environment has a wide range of health benefits in humans and has even been shown to fight cancer in mice, but the underlying mechanisms have been unclear. A study published April 25 in Cell Reports reveals that cognitive stimulation, social interactions, and physical activity increase lifespan in mice with colon cancer by triggering the body's wound repair response.

Apr 12, 2017

Huntsman Cancer Institute Investigators Elected to American Academy of Arts and Sciences

University of Utah professors Bradley R. Cairns, professor and chair of Oncological Sciences and senior director of Basic Science at Huntsman Cancer Institute; Dana Carroll, distinguished professor of Biochemistry and HCI investigator; and Christopher D. Hacon, distinguished professor of Mathematics, were raised to a high honor in science today with their election to the American Academy of Arts and Sciences.

Mar 08, 2017

Huntsman Cancer Institute Partners with National Cancer Institute on National Colorectal Cancer Outreach and Education Initiative

Huntsman Cancer Institute (HCI) at the University of Utah is partnering with the National Cancer Institute (NCI) to implement a nationwide colorectal cancer outreach and education initiative in support of increasing colorectal cancer screening rates in rural, frontier, and culturally diverse communities in Utah. The Screen to Save Initiative will launch in March at HCI and 48 other cancer centers around the nation, targeting average risk adults age 50 and older.

Feb 15, 2017

Huntsman Cancer Institute Scientists Discover How Epithelial Cells Maintain Constant Cell Numbers

Research published today in Nature from scientists at Huntsman Cancer Institute (HCI) at the University of Utah shows how epithelial cells naturally turn over, maintaining constant numbers between cell division and cell death.

Jan 30, 2017

Actors Jeremy Renner and Elizabeth Olsen Visit Huntsman Cancer Institute Patients and Staff

Actors Jeremy Renner and Elizabeth Olsen spent two hours visiting patients at Huntsman Cancer Institute on Sunday, January 22. The “Avengers: Age of Ultron” and “Captain America: Civil War” co-stars were in town promoting their Sundance film “Wind River.” Before flying back to Los Angeles, they took time to stop by the hospital and talk with cancer patients and staff.

Jan 12, 2017

Huntsman Cancer Institute Research Holds Promise for Personalized Lung Cancer Treatments

New research from scientists at Huntsman Cancer Institute (HCI) at the University of Utah uncovered distinct types of tumors within small cell lung cancer that look and act differently from one another. Scientists also identified a targeted drug combination that worked well with one specific tumor type. The study was published today in Cancer Cell. The findings suggest small cell lung cancer should not be treated as a uniform disease

Jan 10, 2017

Huntsman Cancer Institute Joins Nation’s Cancer Centers to Endorse Updated HPV Vaccine Recommendations

Recognizing a critical need to improve national vaccination rates for human papillomavirus (HPV), Huntsman Cancer Institute (HCI) at the University of Utah has united with each of the 69 National Cancer Institute (NCI)-designated cancer centers in support of recently revised recommendations from the Centers for Disease Control and Prevention (CDC).

Dec 19, 2016

Huntsman Cancer Institute Leads International Colorectal Study

Huntsman Cancer Institute (HCI) at the University of Utah will head an international study to find out how lifestyle and other health factors impact colon and rectal cancer outcomes. HCI was awarded an $8.8 million grant from the National Institutes of Health to lead and expand an ongoing project in colon cancer research.

Nov 10, 2016

Huntsman Cancer Institute Commits to “Just Bag It” To Eradicate Deadly Medical Error

As part of its ongoing commitment to patient safety, Huntsman Cancer Institute (HCI) at the University of Utah is standing with a national campaign to end a dangerous chemotherapy error. Just Bag It: The NCCN Campaign for Safe Vincristine Handling, launched today by the National Comprehensive Cancer Network® (NCCN®), encourages health care providers to adopt a policy to always dilute and administer the medication vincristine in a mini IV-drip bag to prevent the improper administration of the drug.

Oct 27, 2016

Promise of Better Targeted Treatments Now Possible in Children’s Brain Cancer

SALT LAKE CITY—More than 4,000 children and teens are diagnosed with brain cancer each year and the disease kills more children than any other cancer. Writing this week in the journal Cell Reports, researchers at Huntsman Cancer Institute (HCI) at the University of Utah report they have identified an existing group of drugs that appear to reduce or eliminate a certain subgroup of childhood brain cancers while sparing normal brain tissue. The research was conducted using a new zebrafish animal model system developed by the researchers, which closely resembles an aggressive subtype of pediatric brain tumors.

Oct 13, 2016

Born Rich or Poor? Where You Begin Life Affects Cancer Risk Later

Researchers at Huntsman Cancer Institute (HCI) at the University of Utah announced today the results of a study that found that circumstances in childhood, such as parental occupation at birth and neighborhood income, may be associated with different risks of certain cancers later in life.

Sep 29, 2016

Huntsman Cancer Institute at the University of Utah Announces New Leadership

SALT LAKE CITY—Officials at University of Utah Health Care (UUHC) today announced that Ben Tanner, Huntsman Cancer Institute’s (HCI) current director of clinical operations and chief operating officer (COO) has been named the cancer hospital’s executive director, replacing Ray Lynch, who is retiring after 13 years of service. Tanner will assume his duties immediately.

Sep 14, 2016

Improving Cancer Prevention and Care among Underserved Individuals Focus of New Huntsman Center for HOPE

Huntsman Cancer Institute at the University of Utah today announced the creation of a new center to be housed in the soon-to-be-completed expansion of HCI’s research enterprise, the Primary Children’s and Families’ Cancer Research Center. The new center will be called the Huntsman Center for Health Outcomes and Population Equity (HOPE) and will focus on discovering new ways to prevent and treat cancer among underserved populations, including individuals living in poverty and residents of rural (between 6.1 and 99.9 persons/sq. mile) and frontier (<6.1 persons/sq. mile) areas.

Jun 21, 2016

Dalai Lama Meets with Huntsman Cancer Institute Leaders, Blesses Patients

His Holiness the 14th Dalai Lama of Tibet met with patients and leaders of Huntsman Cancer Institute and the University of Utah during a brief visit to Huntsman Cancer Institute today, Tuesday, June 21. His visit coincides with his appearance later in the afternoon at the University’s Jon M. Huntsman Center where he will speak about compassion and universal responsibility.

Jun 02, 2016

Oliver Sacks’ Rare Eye Disease Gives Rise to New Strategy for Treating Difficult Cancers

Eye cancer took the life of author and neurologist Oliver Sacks last year, bringing attention to the rare and deadly disease. Scientists have tried to develop precision treatments against cancers like this one, but the mutations that cause them have proven difficult to block with drugs.

May 05, 2016

Study Contradicts Belief that Cancer Protects against Alzheimer’s

Despite studies that claim people with cancer are less likely to develop Alzheimer’s disease—raising the possibility that what triggers cancer also prevents the neurodegenerative disorder—a new investigation finds a more somber explanation. Many cancer patients don’t live long enough to get Alzheimer’s. The research, led by investigators at Huntsman Cancer Institute at the University of Utah, was published in The Journals of Gerontology: Series B.

Apr 04, 2016

Huntsman Cancer Institute CEO to Join Federal Moonshot Blue Ribbon Panel

Huntsman Cancer Institute’s CEO and director, Mary Beckerle, PhD, has been asked to join Vice President Joe Biden’s Moonshot Program Initiative as an invited member of a new Blue Ribbon Panel, tasked with advising the National Cancer Advisory Board (NCAB) on the scientific opportunities available to accelerate progress against cancer and evaluate potential new investments in cancer research.

Mar 22, 2016

Pulitzer Prize Winning Author Dr. Sid Mukherjee Joins HCI Panel Discussion

There are limits to precision medicine – the genome-mapping wave permeating health care these days. And no one is more aware of the gap between technology and science than cancer doctors. A panel gathered at Huntsman Cancer Institute (HCI) March 23 warned about the boundaries, even the dangers, of relying too much on “big data” to treat patients with uniquely variable diseases.

Mar 22, 2016

New Treatment Reduces Precancerous Polyps in Hereditary Cancer Patients

Inheriting a mutation in the APC gene leads to a nearly 100% lifetime risk of colorectal cancer. While colon cancer can be kept at bay by removing the large intestine, these patients also have up to a 15% risk of getting cancer in the small intestine, which is the leading cause of cancer death in this patient group. A new study published in the Journal of the American Medical Association (JAMA), has identified the first prevention treatment for these patients, a two-drug combination that significantly reduces the number and size of precancerous polyps in the small intestine.

Feb 29, 2016

Huntsman Cancer Institute Hosts Vice President Joe Biden

(February 26, 2016) – Today Huntsman Cancer Institute (HCI) hosted Vice President Joe Biden as a part of the White House administration’s “moonshot” initiative to double the rate of progress toward curing cancer. During his visit, the vice president toured the facility, was given an inside look at the Utah Population Database and participated in a roundtable discussion comprised of Huntsman Cancer Foundation board chairman Jon Huntsman Jr., CEO and director of HCI Dr. Mary Beckerle and Senator Orrin Hatch. Local cancer survivors and physicians, researchers and experts in the field also participated in the roundtable.

Dec 17, 2015

When Cancer of Unknown Origin Strikes, Family Members Are At Increased Risk

Cancer usually begins in one location and then spreads, but in 3-5% of cancer patients, the tissue where a cancer began is unknown. In these individuals a cancer diagnosis is made because it has metastasized to other sites. Patients with these so-called “cancers of unknown primary,” or CUP, have a very poor prognosis, with a median survival of three months. A new study in the Journal of the American Medical Association (JAMA) Oncology finds that family members of CUP patients are at higher risk of developing CUP themselves, as well as cancers of the lung, pancreas, colon, and some cancers of the blood.

Nov 19, 2015

Possible New Mechanism for Aspirin's Role in Cancer Prevention

Aspirin has been shown to decrease the risk of colorectal cancer and possibly other cancers. However, the risk of side effects, including in some cases severe gastrointestinal bleeding, makes it necessary to better understand the mechanisms by which aspirin acts at low doses before recommending it more generally as a preventative, says Cornelia Ulrich, PhD, Senior Director of Population Sciences at Huntsman Cancer Institute in Salt Lake City.

Oct 28, 2015

A Cancer-Killing Cold Sore Virus Fights Late Stage Melanoma

The U.S. Food and Drug Administration announced October 27 that it has approved, for the first time, an oncolytic (cancer-killing) viral therapy in the U.S. The drug was approved for use against late stage melanoma, a deadly skin cancer that can be difficult to treat.

Oct 08, 2015

Why Elephants Rarely Get Cancer

Why elephants rarely get cancer is a mystery that has stumped scientists for decades. A study led by researchers at Huntsman Cancer Institute (HCI) at the University of Utah and Arizona State University, and including researchers from the Ringling Bros. Center for Elephant Conservation, may have found the answer.

Jul 22, 2015

Poor Survival in Multiple Myeloma Patients Linked to Genetic Variation

As part of a multi-institutional effort, researchers with Huntsman Cancer Institute at the University of Utah have found that multiple myeloma patients with a genetic variation in the gene FOPNL die on average 1-3 years sooner than patients without it.

Jul 09, 2015

National Cancer Institute Awards Huntsman Cancer Institute Elite Comprehensive Cancer Center Designation

The National Cancer Institute (NCI) has awarded Huntsman Cancer Institute (HCI) at the University of Utah its Comprehensive Cancer Center status, the highest designation possible.

Apr 21, 2015

Study Finds Childhood Cancer Survivors More Likely to Be Enrolled in Social Security Support as Adults

Children with cancer have a good chance of surviving the disease—today more than 80% survive due to advances in treatment and care. However, recent studies have shown that some of these more than 420,000 U.S. childhood cancer survivors face future health related challenges as they become adults such as a second cancer diagnosis, cardiac failure, or other severe medical complications.

Apr 13, 2015

Characterization of the Nutrient Needs of Triple Negative Breast Cancer Leads to the Identification of a Molecular Signature for Cancer Outcomes

Compared to other types of breast cancer, triple negative breast cancers are often more aggressive and have fewer treatment options. In a new study published in the journal Proceedings of the National Academy of Sciences (PNAS), researchers at Huntsman Cancer Institute and the University of Utah have identified a molecular mechanism that triple negative breast cancer cells use to survive and grow.

Apr 06, 2015

Noted UCSF Scientist Joins Research Team at Huntsman Cancer Institute

Martin McMahon, Ph.D., joins Huntsman Cancer Institute (HCI) at the University of Utah in August as Professor in the Department of Dermatology and HCI Senior Director of Pre-Clinical Translation. Professor McMahon is currently the Efim Guzik Distinguished Professor of Cancer Biology at the University of California, San Francisco and Assistant Director of Professional Education and Co-leader of the Helen Diller Family Comprehensive Cancer Center (HCFCCC) Developmental Therapeutics Program.

Jan 27, 2015

Cell Mechanism Discovered That May Cause Pancreatic Cancer

Researchers at Huntsman Cancer Institute (HCI) at the University of Utah have found that defects in how cells are squeezed out of overcrowded tissue to die, a process called extrusion, may be a mechanism by which pancreatic cancer begins. From these findings, they may have identified an effective way to reverse the defective extrusion’s effects without destroying normal tissues nearby. The results were published in the latest edition of the journal eLife.

Jan 08, 2015

New Study Findings Help Physicians and Patients Determine Prostate Cancer Risk

A discovery by researchers at Huntsman Cancer Institute shows that looking at whether a man’s uncles and great-grandparents, among other second- and third-degree relatives, had prostate cancer could be as important as looking at whether his father had prostate cancer. A more complete family history would give physicians a new tool to decide whether or not a PSA test was appropriate.